ARTICLE | Company News
Biovail cardiovascular news
May 26, 2008 7:00 AM UTC
Biovail will pay $24.6 million to the U.S. Department of Justice to settle an investigation in connection with the 2003 launch of Cardizem LA diltiazem to treat hypertension. The company will plead g...